Protalix BioTherapeutics (PLX)
Protalix BioTherapeutics Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -5.904M | -8.913M | -8.875M | -13.69M | -5.052M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 0.93M | 0.933M | 0.897M | 0.923M | 0.878M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 0.059M | 0.396M | 0.478M | 0.186M | 0.339M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 0.989M | 1.329M | 1.375M | 1.109M | 1.217M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | -1.366M | 0.972M | -0.647M | 7.757M | -0.153M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Operating Activities | -6.281M | -6.612M | -8.147M | -4.823M | -3.988M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -0.81M | -0.704M | -0.983M | -1.412M | -2.604M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Investing Activities | -0.042M | -0.043M | -0.045M | -0.031M | -0.046M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | -0.852M | -0.747M | -1.028M | -1.443M | -2.65M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity Issued | 25.57M | 0.014M | 0.004M | -0.027M | 20.94M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Financing Activities | 25.57M | 0.014M | 0.004M | -0.027M | 20.94M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | 0.163M | -0.218M | -0.319M | 0.12M | 0.029M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Change in Cash & Cash Equivalents | 18.60M | -7.563M | -9.49M | -6.173M | 14.33M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 27.00M | 35.90M | 27.00M | 34.56M | 44.05M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 45.60M | 27.00M | 34.56M | 44.05M | 50.23M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
